Skip to main content
Clinical Trials/CTRI/2022/01/039100
CTRI/2022/01/039100
Not yet recruiting
Phase 4

Effect of intrathecal Dexmedetomidine as an adjuvant to hyperbaric bupivacaine in orthopaedic lower limb surgery: An Intervention Study

Department of Anaesthesiology0 sites0 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Health Condition 1: O- Medical and Surgical
Sponsor
Department of Anaesthesiology
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
Department of Anaesthesiology

Eligibility Criteria

Inclusion Criteria

  • 1\.Age 18 to 65 years
  • 2\.Both genders
  • 3\.ASA grade I and II

Exclusion Criteria

  • 1\.History of spine surgery, hepatic failure, neuromuscular disorders 2\.chronic history of headache, backache and infection in back 3\.Any absolute or relative contraindication to study drug
  • 4\.Uncooperative patients 5\.Coagulopathy 6\.Patient with history of cardiac or respiratory diseases

Outcomes

Primary Outcomes

Not specified

Similar Trials